Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher G Bunick

Showing results (131-140 of 159) with videos related to

Pageof 16
Sort By:
Journal of the American Academy of Dermatology|July 25, 2022
The CONTROL study: A randomized, double-blind vehicle-controlled phase 2b study of novel topical isotretinoin formulation demonstrates improvement in recessive X-linked and autosomal recessive lamellar congenital ichthyosisJoyce M C Teng, Christopher G Bunick, Scott Guenthner, et al.
American Journal of Clinical Dermatology|January 14, 2026
Switching from Dupilumab to Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis After Inadequate Response to Dupilumab: Efficacy and Safety Results from Period 2 of Phase 3b/4 Study (LEVEL UP)Christopher G Bunick, Nina Magnolo, Angela Moore, et al.
Dermatologic Therapy|December 19, 2021
Sarecycline treatment for acne vulgaris: Rationale for weight-based dosing and limited impact of food intake on clinical efficacyAyman Grada, James Q Del Rosso, Emmy Graber, et al.
Frontiers in Medicine|December 26, 2022
Reduced blood-brain barrier penetration of acne vulgaris antibiotic sarecycline compared to minocycline corresponds with lower lipophilicityAyman Grada, James Q Del Rosso, Angela Y Moore, et al.
British Journal of Clinical Pharmacology|December 17, 2025
Maximal use of 0.05% topical isotretinoin in patients with congenital ichthyosis results in low systemic exposureHolm Schneider, Christopher G Bunick, Kathrin Hillmann, et al.
Dermatology and Therapy|August 12, 2023
Circadian Oscillations of Minimal Erythema Dose (MED) are Also Influenced by Diet in Patients with Psoriasis: A Chronomedical StudyGiovanni Damiani, Alessia Pacifico, Egeria Scoditti, et al.
The Journal of Investigative Dermatology|June 28, 2025
The Epidemiology of Atopic Dermatitis among Adults and Adolescents with Alopecia Areata in the United StatesChristopher G Bunick, April W Armstrong, Ayman Grada, et al.
American Journal of Clinical Dermatology|April 24, 2025
Correction to: Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysisAmalie Thorsti Møller Rønnstad, Christopher G Bunick, Raj Chovatiya, et al.
American Journal of Clinical Dermatology|November 26, 2025
Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-AnalysisAmalie Thorsti Møller Rønnstad, Daniel Isufi, Christopher G Bunick, et al.
American Journal of Clinical Dermatology|March 5, 2025
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysisAmalie Thorsti Møller Rønnstad, Christopher G Bunick, Raj Chovatiya, et al.
Pageof 16

Showing results (131-140 of 159) with videos related to

Sort By:
Pageof 16
Journal of the American Academy of Dermatology|July 25, 2022
The CONTROL study: A randomized, double-blind vehicle-controlled phase 2b study of novel topical isotretinoin formulation demonstrates improvement in recessive X-linked and autosomal recessive lamellar congenital ichthyosisJoyce M C Teng, Christopher G Bunick, Scott Guenthner, et al.
American Journal of Clinical Dermatology|January 14, 2026
Switching from Dupilumab to Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis After Inadequate Response to Dupilumab: Efficacy and Safety Results from Period 2 of Phase 3b/4 Study (LEVEL UP)Christopher G Bunick, Nina Magnolo, Angela Moore, et al.
Dermatologic Therapy|December 19, 2021
Sarecycline treatment for acne vulgaris: Rationale for weight-based dosing and limited impact of food intake on clinical efficacyAyman Grada, James Q Del Rosso, Emmy Graber, et al.
Frontiers in Medicine|December 26, 2022
Reduced blood-brain barrier penetration of acne vulgaris antibiotic sarecycline compared to minocycline corresponds with lower lipophilicityAyman Grada, James Q Del Rosso, Angela Y Moore, et al.
British Journal of Clinical Pharmacology|December 17, 2025
Maximal use of 0.05% topical isotretinoin in patients with congenital ichthyosis results in low systemic exposureHolm Schneider, Christopher G Bunick, Kathrin Hillmann, et al.
Dermatology and Therapy|August 12, 2023
Circadian Oscillations of Minimal Erythema Dose (MED) are Also Influenced by Diet in Patients with Psoriasis: A Chronomedical StudyGiovanni Damiani, Alessia Pacifico, Egeria Scoditti, et al.
The Journal of Investigative Dermatology|June 28, 2025
The Epidemiology of Atopic Dermatitis among Adults and Adolescents with Alopecia Areata in the United StatesChristopher G Bunick, April W Armstrong, Ayman Grada, et al.
American Journal of Clinical Dermatology|April 24, 2025
Correction to: Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysisAmalie Thorsti Møller Rønnstad, Christopher G Bunick, Raj Chovatiya, et al.
American Journal of Clinical Dermatology|November 26, 2025
Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-AnalysisAmalie Thorsti Møller Rønnstad, Daniel Isufi, Christopher G Bunick, et al.
American Journal of Clinical Dermatology|March 5, 2025
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysisAmalie Thorsti Møller Rønnstad, Christopher G Bunick, Raj Chovatiya, et al.
Pageof 16